Anna Ponzianelli, Phd Email & Phone Number

Rome, It

Italy

Roma

HTA Head is a NVS responsibile for the Institutional Relation Management and Access strategy.In this role HTA Affairs Head is in charge of AIFA relation management for the Company.Definition of Price and Reimbursement Strategy to be followed with AIFA and the relevant Commission as CTS and CPR and the relevant soubgroups.Institutional Relation Management Health Institutional Bodies such as ISS, MoH and AIFA.Develop different strategies in line with possible future scenarios in Italian Pharmaceutical Market to support MA also in terms partnership with Associations and Institutions (National and Regional) in the Pharmaceutical Enviorment with the aim to support a sustainable development.Develop European project on treatment adherence of the elderly and Chronic pathologies management: Population Health ProgrammesDevelop Value Based Healthcare Systems Projects in partnership with Institutions and AcademiaFarmindustria relations management with a major focus on Regional and Technical/Scientific Areas such as HTA, Value Based Healthcare and HEORBoard Member of Italian Society of HTA (SIHTA)Vice President of Italian Association of Regulatory Activities (SIARV) - GdL Access Coordinator both for SIARV and AFI and SIARVNews Co-DirectorProfessor at ALTEMS both in Master in Market Access (II level) and Biotechnology (I level).Contributor ad a speaker in several Courses and Congresses.

Rome

Institutional Affairs Head is a NVS responsibile for the Institutional Relation Management and Access strategy with the final report to Patient Access Head.In this role th ISH is in charge of AIFA relation management for the Company.Definition of Price and Reimbursement Strategy to be followed with AIFA and the relevant Commission as CTS and CPR and the relevant soubgroups.Institutional Relation Management Health Institutional Bodies such as ISS and AIFA.Develop different strategies in line with possible future scenarios in Italian Pharmaceutical Market to support MA also in terms partnership with Associations and Institutions (National and Regional) in the Pharmaceutical Enviorment with the aim to support a sustainable development.Develop European project on treatment adherence of the elderly and Chronic pathologies management with Market AccessDevelop Value Based Healthcare Systems Projects in partnership With VIHTALI.Manage organization of Open AIFA and Early AdviceFarmindustria relations management with a major focus on Regional and Technical/Scientific Areas such as HTA, and RWE, Value Based Healthcare and Health Economics.Vice President of Italian Association of Regulatory Activities (SIAR)SIAR News Co-DirectorProfessor at ALTEMS both in Master in Market Access (II level) and Biotechnology (I level).Contributor ad a speaker in several Courses and Congresses.

Origgio - Roma

Head of Territory AccessRegional Market Access Responsible for NVS Group Company for Centre Italy for all Company Drugs with final report to Patient Access Head• Centre Italy KAM Team Coordination: 8 Regional KAM responsible for 6 Regiom: Toscana, Umbria, Lazio, Marche, Abruzzo, Molise, Sardegna (in charge of both Hospital/District and Region Commercial and Market Access) • Responsible for regional MKT access introduction of Novartis portfolio: coordination of regional and hospital formulary submissions (Cost ohf Illness, Budget Impact & HTA methodology)• Responsible of International Project of Regional Market Access “Paradigm” for New Drugs.• The activities are driven in synergy with MA&TA Head and BU Franchise Head for Novartis Farma and Patient Access Head Head and Country Head for NVS Vaccines and Biosimilar.

National Sales Manager – Retina Business FranchiseSales Responsible for Retina hospital biological drugs (Lucentis e Visudyne) with final report to Retina Business Franchise Head • Specialty Sales Force set up and re-sizing. Final field force organization: 14 Territory Retina Accounts• Responsible for regional MKT access introduction: coordination of regional and hospital formulary submissions (HTA methodology)• performance forecast & analysis

Retina Marketing Manager- Business Unit Ophthalmology Responsible and Supervisor of one Product Manager and, 4 Retina Accont Manager - with final report to Ophtha Business Unit Head• “Lucentis launch team” leader, first anti-VEGF drug in ophthalmology: coordination of MKT introduction activities (Regulatory, Sales set up, Communication, MKTG intelligence)• Marketing and Medical Strategy coordination for Retina Area (Private and Public Hospital MKT) • Responsibility of Retina Sales and Activities including Project management• A&P management and sales performance forecast & analysis

Photodynamic Therapy Business Manager – Business Unit OphthalmicsResponsible and Supervisor of one Product Managers and 3 VIKAM (Visudyne Key Account Managers), one Regulatory Affair Specialist and one Assistant – with final report to Country Head; • Business Development of Pharmaceutical Retina Business• National, Regional and Local Market Access through FE Models (Cost of Illness Analysis, Trials and Development of specific new formulary.• Clinical trial Coordination• Strategic marketing coordination;• Sales Coordination• Trend analysis and forecast;• Responsible of commercial policies;

Responsible and Supervisor Regulatory Affair Specialist & anAssistant – with final report to Country Head; • Market Access & Insitutional Affairs responsible in charge of Marketing Authorization of Drugs and Medica device for both Ophthalmics and Optics Business units.• Ministery of Health Dept SH contact and management• Coordination Marketing Authorization LCM Management activities for company Producs• Phase II-III and IV Clinical trial Coordination

Post Graduate Degree, Leadership In Medicina

Post Graduation Degree In Pharmacoeconomics

Phd, Pharmacology, Pharmacognosy And Toxicology

Graduation, Biology

Education record